Mike Grippo Senior Vice President, Strategy & Corporate Development at Catalent Pharma Solutions

Mike Grippo oversees the strategy and corporate development functions of the company, as well as its scientific team.

Mr. Grippo joined Catalent as Vice President of Corporate Development in 2016, and prior this was Vice President of Corporate Development for CR Bard. Earlier in his career he also held positions with Hill-Rom Holdings, SG Cowen and UBS Securities. Mr. Grippo holds a bachelor’s degree from Princeton University and earned an MBA in Finance from New York University.